Biora Therapeutics Inc.

NASDAQ: PROG · Real-Time Price · USD
0.88
-0.04 (-3.96%)
At close: May 09, 2022, 6:00 AM

Biora Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Cash & Equivalents
88.4M
Short-Term Investments
n/a
Long-Term Investments
n/a
Other Long-Term Assets
326K
Receivables
653K
Inventory
n/a
Other Current Assets
9.38M
Total Current Assets
98.43M
Property-Plant & Equipment
4.01M
Goodwill & Intangibles
6.07M
Total Long-Term Assets
10.41M
Total Assets
108.84M
Account Payables
8.71M
Deferred Revenue
n/a
Short-Term Debt
n/a
Other Current Liabilities
52.9M
Total Current Liabilities
61.61M
Long-Term Debt
126.39M
Other Long-Term Liabilities
5.81M
Total Long-Term Liabilities
132.21M
Total Liabilities
193.81M
Total Debt
n/a
Common Stock
146K
Retained Earnings
-788.69M
Comprehensive Income
n/a
Shareholders Equity
-84.98M
Total Investments
n/a